Alexion Pharmaceuticals plans to acquire Synageva BioPharma for $8.4 billion, the companies said today, in a deal that will expand the buyer's portfolio of metabolic treatments with what it boasted will be �the most robust rare disease pipeline in biotech.
Productivity in the U.S. fell in the first quarter, triggering the largest back-to-back decline in more than two decades and pushing up worker costs as the world's largest economy almost stalled.
This week, Tesla invited journalists to an announcement at the company's base in Hawthorne, California, in which Elon Musk is expected to give details about a new product unrelated to his line of electric cars.
european union flag Europe has unveiled a new blueprint for the digital industry designed to boost competition and make life easier for consumers.
... * To sell bakery business this month. * Raises number of U.S. outlets it plans to sell this year. * First-qtr same-restaurant sales up 3.2 pct vs est.